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Abstract 
Purpose: We aimed to explore the effects of low energy availability (EA)[15 kcal·kg lean body mass 
(LBM)
-1
·d
-1
] achieved by diet or exercise on bone turnover markers in active, eumenorrheic women. 
Methods: By using a crossover design, ten eumenorrheic women (VO2 peak: 48.1±3.3 ml·kg
-1
·min
-1
) 
completed all three, 3-day conditions in a randomised order: controlled EA (CON; 45 kcal·kgLBM
-
1
·d
-1
), low EA through dietary energy restriction (D-RES; 15 kcal·kgLBM
-1
·d
-1
) and low EA through 
increasing exercise energy expenditure (E-RES; 15 kcal·kgLBM
-1
·d
-1
), during the follicular phase of 
three menstrual cycles. In CON, D-RES and E-RES, participants consumed diets providing 45, 15 and 
45 kcal·kgLBM
-1·
d
-1
. In E-RES only, participants completed supervised running sessions (129±10 
min·d
-1
) at 70% of their VO2 peak that resulted in an exercise energy expenditure of 30 kcal·kg LBM
-
1
·d
-1
. Blood samples were collected at baseline (BASE) and at the end of the 3-day period (D6) and 
analysed for bone turnover markers (-CTX and P1NP), markers of calcium metabolism (PTH, 
albumin-adjusted Ca, Mg and PO4) and hormones (IGF-1, T3, insulin, leptin and 17β-oestradiol). 
Results: In D-RES, P1NP concentrations at D6 decreased by 17% (BASE: 54.8±12.7 µg·L
-1
, D6: 
45.2±9.3 µg·L
-1
, P<0.001, d=0.91) and were lower than D6 concentrations in CON (D6: 52.5±11.9 
µg·L
-1
, P=0.001). P1NP did not change significantly in E-RES (BASE: 55.3±14.4 µg·L
-1
, D6: 
50.9±15.8 µg·L
-1
, P=0.14). β-CTX concentrations did not change following D-RES (BASE: 
0.48±0.18 µg·L
-1
, D6: 0.55±0.17 µg·L
-1
) or E-RES (BASE: 0.47±0.24 µg·L
-1
, D6: 0.49±0.18 µg·L
-1
) 
(condition x time interaction effect, P=0.17). There were no significant differences in P1NP (P=0.25) 
or β-CTX (P=0.13) responses between D-RES and E-RES. Both conditions resulted in reductions in 
IGF-1 (-13% and –23% from BASE in D-RES and E-RES, both P<0.01) and leptin (-59% and –61% 
from BASE in D-RES and E-RES, both P<0.001); T3 decreased in D-RES only (-15% from BASE, 
P=0.002) and PO4 concentrations decreased in E-RES only (-9%, P=0.03). Conclusions: Low EA 
achieved through dietary energy restriction resulted in a significant decrease in bone formation but no 
change in bone resorption, whereas low EA achieved through exercise did not significantly influence 
bone metabolism. Both low EA conditions elicited significant and similar changes in hormone 
concentrations.  
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1. Introduction1  
Active individuals may experience low energy availability (EA) though dietary energy restriction, 
exercise energy expenditure  or a combination of the two [1]. Low EA has been associated with low 
bone mass, impaired bone micro-architecture and increased risk for stress fracture injury [2-5]. These 
unfavourable bone outcomes have been highlighted by the Female Athlete Triad [6, 7] and the 
Relative Energy Deficiency in Sports (RED-S) model [8]. Short-term studies are important for 
providing insight into the time course over which bone metabolic changes occur, when periods of low 
EA are initiated [9-11]. We have previously shown that five days of low EA, at 15 kcal·kgLBM
-1
·d
-1
, 
achieved through dietary energy restriction and exercise energy expenditure resulted in decreased 
bone formation and increased bone resorption in active, eumeorrheic women, but not men [9]. The 
individual contribution of exercise and diet on these responses, however, is unknown.  
To date, short-term studies (< 7 days) that have compared the effects of low EA by different 
modalities (i.e., diet vs. exercise or diet vs. diet plus exercise) are lacking, and findings from long-
term interventional studies on bone parameters are equivocal. Previous research has shown no skeletal 
benefits from exercise in weight loss programmes [12, 13], maintenance of bone mass with either 
dietary energy restriction and/or exercise-induced energy restriction [14, 15] or amelioration and 
prevention of weight loss-associated bone loss with the addition of exercise [16-19]. Notably, these 
studies have been conducted in middle-aged [13, 16, 17] or elderly [12, 18, 19] overweight and obese 
populations, but no previous study has been performed in active, eumenorrheic women. Most trials 
have compared diet to diet plus exercise [12, 13, 18], but few have compared diet to exercise alone 
[16, 17]. and have utilised exercise protocols suitable for obese/overweight (i.e., exercise of lower 
intensity or exercise modes offering no or limited osteogenic stimulus, such as walking and cycling), 
                                                     
1 Abbreviations  
ACa, Albumin-adjusted calcium; ANOVA, Analysis of variance; AUC, Area under the curve; BASE, Baseline; BMD, Bone 
mineral density; BMI, Body mass index; CON, Controlled energy availability trial; β-CTX, β-carboxyl-terminal cross-linked 
telopeptide of type I collagen; D, Day; D-RES: Low energy availability trial though diet; CV, Coefficient of variation; 
DXA, Dual energy X-ray absorptiometry; EA, Energy availability; E-RES, Low EA trial though exercise; ECLIA, Electro-
chemiluminescence immunoassay; EDTA, Ethylenediaminetetraacetic acid;; ELISA, Enzyme-linked immunosorbent assay; 
IGF-1, Insulin-like growth factor 1; IPAQ, International physical activity questionnaire; LBM, Lean body mass; MET, 
Metabolic equivalent; Mg, Magnesium; P1CP, Carboxyl-terminal propeptide of procollagen type 1; P1NP, Amino-terminal 
propeptide of procollagen type 1; PO4, Phosphate; PTH, Parathyroid hormone; RED-S, Relative energy deficiency in sport, 
SD, Standard deviation; T3, Triiodothyronine; VO2 peak, Peak aerobic capacity. 
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rather than active individuals. Given that active individuals practise periods of intense training 
resulting in high exercise energy expenditure, which is not accompanied by an increase in dietary 
energy intake and/or severely restrict their dietary energy intake during non-training days or the off-
season [1, 20], it would be valuable  to explore the effects of low EA, attained by diet or exercise, on 
bone metabolic responses in this population. 
Low EA has been associated with changes in metabolic and reproductive hormones [4, 5, 9, 10], 
which may depend on the way in which low EA is achieved [21-23]. Acute energy deficit 
(approximately 800-1200 kcal·d
-1
) achieved via dietary energy restriction results in decreased peptide 
YY and increased ghrelin concentrations, but no compensatory alterations occur after exercise-
induced energy deficit [21, 22]. In contrast, leptin and insulin appear to be similarly reduced in 
response to low EA achieved through dietary restriction alone or combined with exercise [24]. Further 
evidence from studies on anorexia nervosa and functional hypothalamic amenorrhoea suggest that low 
EA, regardless of origin, results in  oestrogen deficiency with negative consequences for bone health 
[23]. A systematic approach to simultaneously determine changes in bone metabolism, metabolic and 
reproductive hormone responses to diet- and exercise-induced low EA in women with normal bone 
health and reproductive function is lacking.  
The aim of this study was to examine and compare the effects of low EA, at 15 kcal·kgLBM
-1
·d
-1
, 
achieved by either dietary energy restriction or  exercise energy expenditure on bone turnover markers 
in active, eumenorrheic women.   
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2. Methods 
2.1. Participants  
Ten eumenorrheic women (Table 1.) provided written informed consent to take part in the study. The 
study was approved by the Nottingham Trent University Human Research Ethics Committee and the 
East Midlands NHS Research Ethics Committee (14/EM/1156) and was conducted in accordance with 
the Declaration of Helsinki. Inclusion criteria were 1) age: 18-40 years, 2) Caucasian, 3) self-reported 
regular and frequent menstrual cycles (menstrual cycle interval between 24 and 35 days), 4) currently 
injury free, 5) participation in moderate and vigorous exercise for ≥3 hours·week-1 and 6) BMI 
between 18.5 and 30 kg·m
-2
. Exclusion criteria were 1) use of medication or suffering from any 
condition known to affect bone metabolism, 2) bone fracture within the previous year, 3) current 
smokers, 4) breastfeeding, 5) pregnancy, 6) use of any type of hormonal contraception within the past 
six months and 7) self-reported short (<24 days), long (>35 days) or irregular menstrual cycles. These 
criteria were confirmed verbally and in writing by a health screen with the experimenters, menstrual 
cycle questionnaire and the short-form version of International Physical Activity Questionnaire (IPAQ) 
[25].   
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Table 1. Baseline participant characteristics (n=10). (Size: 1column) 
Demographics  
Age (y) 24±3 
Height (m) 1.66±0.05 
Body mass (kg) 61.1±7.0 
BMI (kg·m
-2
) 22.3±2.4 
Body composition  
Body fat (%) 29.3±5.1 
LBM (kg) 41.3±4.1 
Fat-free mass (kg) 44.3±4.3 
BMD T-score 1.10±0.84 
Menstual cycle characteristics   
Length of menstrual cycle (d) 28.5±3.7 
 
Length of flow (d) 4.9±0.9 
 
Training characteristics  
VO2 peak (ml·kg
-1
·min
-1
) 48.1±3.3 
VO2 peak (ml·kgLBM
-1
·min
-1
) 70.9±2.8 
Physical activity (MET-min·week
-1
) 4634±2382 
Dietary and energy expenditure characteristics 
1
Habitual dietary energy intake (kcal·d
-1
) 2092±262 
1
Lifestyle energy expenditure (kcal·d
-1
) 422±123 
1
Habitual EA (kcal·kgLBM·d
-1
) 39.0±5.6 
Values are expressed as means±1SD.  
1
Analysis performed in 8 participants with complete dietary and energy expenditure data.  
BMI: Body Mass Index; LBM: Lean Body Mass; BMD: Bone Mineral Density: VO2 peak: Peak Oxygen 
Capacity; MET: Metabolic Equivalents; d: days; EA: Energy Availability.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
2.2. Experimental design  
The study utilised a randomised (Latin square design), crossover design. Participants completed 
all three experimental conditions; energy-balanced, controlled EA (CON), low EA through diet 
(D-RES) and low EA through exercise (E-RES) (Figure 1.). Participants attended an initial 
preliminary visit (P) to establish inclusion criteria, take baseline measurements and determine 
their fitness level. They also completed a 3-day habitual dietary intake assessment (H1-H3). 
Participants notified the researchers at the onset of menstruation (D1), which indicated the first 
day of the experimental study. On the next morning (D2), a blood sample was collected and 
used as the baseline (BASE) sample prior to each experimental condition. The following 3 days 
of the protocol (D3-D5) were the experimental condition days. Over D3-D5, participants 
undertook CON, E-RES and D-RES. On D6, participants had their body mass measured and had 
a follow-up blood sample (Figure 1.). Due to scheduling constraints, such as the availability of 
participants or the laboratory, it should be acknowledged that D2 may reflect the second or third 
day of participants’ menstrual cycle, with subsequent small deviations (±1 day) in the main 
experimental period (D3-D5). For consistency, we will refer to D2 as BASE, D3-D5 as the main 
experimental period and D6 as the follow-up. 
 
The controlled EA was set at 45 kcal·kgLBM
-1
·d
-1
 and achieved by dietary energy intake 
providing 45 kcal·kgLBM
-1
·d
-1 
without exercise. Both low EA conditions (E-RES and D-RES) 
were administered as 15 kcal·kgLBM
-1
·d
-1
, with this being achieved by dietary energy 
restriction in D-RES and by exercise energy expenditure in E-RES.  In D-RES, participants 
refrained from exercise and in E-RES, participants completed daily exercise sessions (duration: 
129±10 min per day) at an exercise intensity of 70% of their peak aerobic capacity (VO2 peak) 
that resulted in an exercise energy expenditure of 30 kcal·kgLBM
-1
·d
-1
, with dietary energy 
intake at 45 kcal·kgLBM
-1
·d
-1
 (Figure 1.). The onset of conditions was typically separated by 
approximately 28 days, due to each session being initiated in the early follicular phase of the 
menstrual cycle. 
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Figure 1. Overview of the study design. Participants completed all three experimental conditions; 
CON controlled EA (CON), low EA through diet (D-RES) and low EA through exercise (E-RES). 
Preliminary day (P) was performed before the first condition was performed. D1: Day 1 of 
menstruation and identification for experimental protocol initiation. D2: Baseline Testing, D3-D5: 
Condition Days and D6: Follow-up Testing. (Size: 2 columns)  
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2.3. Experimental procedures  
2.3.1. Preliminary assessment  
Participants were weighed wearing tights and t-shirts without shoes on a weighing scale (Seca 875, 
UK), height was obtained barefoot using a stadiometer (Seca 217, UK) and BMI was calculated as 
body mass (kg) divided by the height squared (m
2
). Whole body Dual-energy X-Ray Absorptiometry 
(DXA; GE Lunar Prodigy Healthcare) scans were performed to assess body composition (LBM, fat 
mass) and baseline bone mineral density (BMD). All DXA scans were conducted and analysed by the 
same operator at Nottingham Trent University according to manufacturer’s guidelines. Participants 
provided a urine sample prior to the DXA scan to confirm normal hydration status (<800 mOsmolkg-
1
) via urine-specific gravity (Osmocheck
TM
 refractometer, 2595-ED4, Vitech-Scientific, UK). 
Participants performed a sub-maximal incremental test and a VO2 peak test on a motorised treadmill, 
(HP Cosmos, Germany) using the protocol of  [26], to establish the relationship between running 
speed and oxygen consumption during level running. Expired gas samples were continuously 
collected and analysed by a breath-to-breath automated gas analysis system (ZAN, nSpire Health, 
Germany). The running speed at each stage of the speed lactate incremental test was plotted against 
oxygen consumption (mL·kg·
-1
min
-1
) to determine the sub-maximal relationship between speed and 
oxygen consumption and, in combination with VO2 peak, was used to estimate the running speed 
corresponding to 70% VO2 peak at 0% gradient for the experimental exercise protocol. All participants 
were given accelerometers and food weighing scales (Home Digital Kitchen Scale, UK) to record 
lifestyle energy expenditure and habitual dietary energy intake over a 3-day lead in period (H1-H3; 
Figure 1.). 
2.3.2. Habitual Dietary Energy Intake and Lifestyle Energy Expenditure  
Participants weighed and recorded food intake during H1-H3 to provide information about their 
habitual dietary energy intake. Dietary analysis (macronutrient composition in g and % of total dietary 
energy intake) was performed by using Microdiet™ software. Participants wore an accelerometer 
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(GT3X/GT3XE, Actigraph, Pensacola, FL) during all waking hours, except while bathing, to estimate 
lifestyle energy expenditure.  The equation developed by Freedson et al [27] was used to extract 
lifestyle energy expenditure data.  
2.3.3. Experimental diets 
In CON, D-RES and E-RES participants consumed diets providing 45, 15 and 45 kcal·kgLBM
-1
·d
-1
. 
The experimental diets consisted of the same commercial food products and had standardised 
composition (50% carbohydrates, 20% protein and 30% fat) in all experimental conditions. A 
registered dietitian designed menus for CON trial (45 kcal·kgLBM
-1
·d
-1
)
 
for a reference individual 
with a LBM of 45 kg using Microdiet
TM
 software. For the same reference individual, quantities of all 
food items in CON (45 kcal·kgLBM
-1
·d
-1
) were divided by three in D-RES (15 kcal·kgLBM
-1
·d
-1
), but 
were unchanged in E-RES (45 kcal·kgLBM
-1
·d
-1
). Food quantities in all menus and conditions were 
multiplied by a scaling factor to account for differences in LBM compared to the reference individual. 
All meals were weighed to the nearest 1g (Home Digital Kitchen Scale, UK) and were packaged by 
the study investigators. Adherence to the diets was verbally confirmed throughout the protocol by 
asking the participants whether they consumed the pre-packaged food items in the quantities provided. 
A multivitamin, multi-mineral supplement (A - Z Tablets, Boots, Nottingham, UK-nutritional 
information of this product is available online: http://www.boots.com/boots-a-z-90-tablets-10149653) 
was supplied during D-RES to provide adequate micronutrient intake. 
2.3.4. Exercise energy expenditure 
In E-RES only, participants completed exercise sessions that resulted in an exercise energy 
expenditure of 30 kcal·kgLBM
-1
·d
-1
. Participants ran on a flat treadmill while being continuously 
supervised. Exercise intensity was controlled by setting the treadmill speed to achieve 70% of VO2 peak 
for each participant and exercise was administered in 15-minute bouts, with 5-minute rest periods 
between bouts. Small adjustments in running speed were made throughout the running protocol to 
maintain the exercise intensity at 70% of VO2 peak. To increase compliance, the total duration of the 
exercise per day was split into two sessions of equal duration. Expired gases were continuously 
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collected and analysed using a breath-by-breath analyser (ZAN 600, nSpire Health, Germany). The 
required duration of exercise was determined using the oxygen uptake values and respiratory 
exchange ratio during the first exercise session (D3) and gas analysis was not performed during the 
remainder of the exercise sessions (D3 afternoon-D5) to enhance compliance. Outside of the 
prescribed exercise, participants were instructed to refrain from exercise and perform only sedentary 
activities.  
2.4. Storage and analyses of blood samples 
Blood samples were obtained at the same time of day for each participant and between 07.30-08.15 h 
after an overnight fast (from 20:00 h the previous evening) on D2 (BASE) and D6. For plasma 
[ethylenediaminetetraacetic acid (EDTA) tubes, SARSTED, Nümbrecht, Germany], samples were 
centrifuged immediately at 1509 x g for 10 min at 4
o
C. Venous blood was dispensed into serum tubes 
and allowed to clot at room temperature for 30 min before being centrifuged under the same 
conditions. Resultant plasma and serum were aliquoted into Eppendorf tubes and stored at -80
o
C. -
carboxyl-terminal cross-linked telopeptide of type I collagen (β-CTX), amino-terminal propeptide of 
type 1 procollagen (PINP), parathyroid hormone (PTH) and IGF-1 were analysed in EDTA plasma 
and leptin, insulin, T3, 17β-oestradiol, albumin, calcium (Ca), magnesium (Mg) and phosphate (PO4) 
in serum.  
2.5. Biochemical analysis  
β-CTX, P1NP, PTH, T3 and 17β-oestradiol were measured using electro-chemiluminescence 
immunoassay (ECLIA) (Roche Diagnostics, Burgess Hill, UK) on a Cobas e601 analyser. Inter-assay 
coefficient of variation (CV) for β-CTX was <3% between 0.2 and 1.5 µg·L-1 with sensitivity of 0.01 
µg·L
-1
. P1NP inter-assay CV was <3% between 20-600 µg·L
-1
 with a sensitivity of 8 µg·L
-1
. PTH 
inter-assay CV was <4% between 1-30 pmol·L
-1
 with a sensitivity of 0.8 pmol·L
-1
. Sclerostin was 
measured using an enzyme-linked immunosorbent assay (ELISA) supplied by Biomedica GmbH 
(Vienna Austria) with a sensitivity of 2.6 pmol·L
-1
, which was established from precision profiles (22% 
CV of duplicates) and had a CV of <15% across the range 25-95 pmol·L
-1
. T3 inter-essay CV was <1% 
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between 2.0-3.1 nmol·L
-1 
with a detection limit of 0.3 nmol·L
-1
. The inter-assay CV for 17β-oestradiol 
was <3% between 214.3-2156.7 pmol·L
-1
 with a detection limit of 18.4 pmol·L
-1
. Leptin was 
measured using ELISA (Biovendor, Czech Republic) and had an inter-assay CV of <7% across the 
range 1-50 µg·L
-1
 and a sensitivity of 0.2 µg·L
-1
. IGF-1 was measured using ELISA 
(Immunodiagnostic Systems Ltd, Boldon, UK) and had an inter-assay CV of <2.2% between 24.0-
306.2 ng·mL
-1 
and a sensitivity of 4.4 ng·mL
-1
. Insulin was measured using ECLIA (Roche 
Diagnostics, Burgess Hill, UK), inter-assay CV was <6.1% across the range 44-505 pmol·L
-1
 and 
sensitivity was 1.8 pmol·L
-1
. Ca, albumin and PO4 were measured using standard commercial assays 
supplied by Roche Diagnostics performed on the Roche COBAS c501. The range of measurement in 
serum was 0.05-5.00 mmol·L
-1
 for Ca, 10-70 g·L
-1
 for albumin and 0.10-6.46 mmol·L
-1
 for PO4. 
Fluctuations in protein concentrations, especially albumin, may cause total Ca concentrations to 
change independently of the ionised calcium concentration, as such Ca concentrations were ‘corrected’ 
to give an albumin-adjusted calcium (ACa) value using the following equation: (-0.8 *([Albumin] - 4)) 
+ [Total Ca]. Mg was measured using a commercial assay supplied by Roche Diagnostics and 
analysed on a COBAS c501. The inter-assay CV was 0.9% across the range 0.1-2.0 mmol·L
-1
 and the 
sensitivity was 0.05 mmol·L
-1
.  
2.6. Statistical analysis  
Based on the results of our previous low EA study [9] in active women, in which low EA was 
achieved by a combination of dietary restriction and exercise energy expenditure, the present study 
was powered to detect a change in P1NP (pre: 70.1 ± 15.1 mg·L
-1
; follow-up after 3-days: 60.1±11.6 
mg·L
-1
, P<0.0001) due to low EA achieved by dietary energy restriction or exercise energy 
expenditure. An a priori power calculation determined that 8 women were required to achieve 80% 
power at P<0.05. Statistical analysis was carried out using Statistica 13.0 (Statsoft, USA). All data 
were checked for normality according to the Shapiro-Wilk test and logarithmic transformations were 
employed for non-normally distributed data prior to statistical analyses. Baseline biochemistry and 
body mass prior to each experimental condition were compared with one-way repeated measures 
ANOVA, to assess for differences at baseline. A two-way, repeated measures ANOVA was 
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performed to assess differences between the experimental conditions (CON, D-RES and E-RES) over 
time (BASE, D6) for body mass, bone turnover markers, markers of calcium metabolism, metabolic 
and reproductive hormones. Significant main or interaction effects were followed by Tukey’s post-
hoc analysis. Data are presented as mean±1SD and effect sizes (Cohen’s d; small ≥ 0.20, medium ≥ 
0.50, large ≥ 0.80) [28] are reported. Statistical significance was accepted at the 5% level.  
In addition to the statistical analysis performed on the whole data set, the individual responses of the 
bone turnover markers to D-RES and E-RES were also explored. To be considered a responder, β-
CTX concentrations at D6 in D-RES or E-RES were >BASE (100%), > β-CTX concentrations at D6 
in CON together with a difference >3% to account for CV of β-CTX assay. For P1NP, responders 
were identified if P1NP concentrations at D6 in D-RES or E-RES were <BASE (100%), <P1NP 
concentrations at D6 in CON together with a difference >3% to account for CV for P1NP assay.   
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3. Results  
3.1. Baseline biochemistry and body mass  
There were no significant differences in any bone turnover marker, marker of calcium metabolism, 
metabolic or reproductive hormone between CON, D-RES and E-RES at BASE (all P-values 0.25-
0.90) (Table 2.). There were no differences in body mass prior to CON, D-RES and E-RES (CON: 
60.9±7.0 kg, D-RES: 61.5±7.0 kg, E-RES: 61.1±6.3 kg; P=0.48).  
3.2. Body mass 
Body mass was reduced at D6 compared to BASE (main effect of time, P<0.001), but did not differ 
between conditions (main effect of condition, P=0.82). A significant condition x time interaction 
effect (P<0.001) was shown for body mass. Post-hoc analysis showed a trend towards a reduction in 
body mass in CON (BASE: 60.9±7.0kg, D6:60.3±6.7 kg, P=0.053, d=0.1). Body mass significantly 
decreased from BASE in D-RES (BASE: 61.4±6.8 kg, D6: 59.6±6.5 kg, P<0.001) and E-RES (BASE: 
61.1±6.3 kg, D6: 60.1±6.0 kg, P<0.001). Body mass at D6 in D-RES was also lower than body mass 
in CON (P<0.001) at the same time point.  
3.3. Bone turnover markers 
Mean β-CTX concentrations were inceased at D6 compared to BASE (main effect of time, P=0.044). 
No difference was shown for β-CTX concentrations between CON, D-RES and E-RES (main effect of 
condition, P=0.13) at any time point (condition x time interaction effect, P=0.17) (Table 2.).  
Mean P1NP concentrations were decreased at D6 compared to BASE (main effect of time, P<0.001), 
but did not differ across conditions (main effect of condition, P=0.25). The condition x time 
interaction effect approached significance (P=0.052) (Figure 2., Table 2.). Post-hoc analysis showed 
that P1NP concentrations at D6 decreased by 17% from BASE in D-RES (P<0.001, d=0.91) and were 
lower than P1NP concentrations in CON at the same time point (P<0.001; d=0.71). In E-RES, P1NP 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
concentrations at D6 were not significantly different from BASE (-8% from BASE, P=0.14, d=0.30) 
or from concentration at D6 in D-RES (P=0.10, d=0.43) (Table 2.).  
3.4. Markers of calcium metabolism  
Mean PTH concentrations decreased with time (D6<BASE; main effect of time, P=0.02). PTH 
responses were not different between experimental conditions, as indicated by a non-significant main 
effect of time (P=0.21) and no condition x time interaction effect (P=0.90) (Table 2.).  
Mean ACa, Mg and PO4 concentrations did not change over time (all P values 0.22-0.51). ACa and 
Mg concentrations did not differ between CON, D-RES and E-RES at BASE or D6 (condition x time 
interaction effect, both P values 0.10-0.89). PO4 concentrations  decreased by 9% at D6 from BASE 
in E-RES trial only (P=0.03, d=1.0) (Table 2.).  
3.5. Metabolic and reproductive hormones  
Mean IGF-1 concentrations at D6 decreased from BASE (main effect of time, P=0.01). Mean IGF-1 
concentrations were lower in D-RES compared to CON (main effect of condition, P=0.03). IGF-1 
concentrations at D6 in D-RES and E-RES decreased by 13% (P=0.009, d=0.76) and 23% (P<0.001, 
d=0.97) from BASE and were both significantly lower than IGF-1 concentrations at D6 in CON 
(P<0.001, d>1.0) (Table 2.).  IGF-1 concentrations at D6 were not significantly different between D-
RES and E-RES (P=0.99, d=0.83). 
Mean T3 concentrations at D6 decreased from BASE (main effect of time, P<0.01). T3 concentrations 
at D6 in D-RES were decreased by 15% from BASE (P=0.002, d>1.0) and were lower than the 
concentrations in CON at the same timepoint (P=0.02, d=0.88) (Table 2.). In E-RES, T3 
concentrations at D6 were not significantly different from BASE (P=0.21) 
Mean insulin concentrations remained unchanged over time (main effect of time, P=0.14) and did not 
differ by condition at any time point, as suggested by a non-significant main effect of condition 
(P=0.44) or any condition x time interaction effect (P=0.07) (Table 2.).  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Mean leptin concentrations decreased with time (D6<BASE; P<0.001). Overall, leptin concentrations 
were different across conditions (main effect of condition, P<0.001; D-RES<CON, P=0.006 and E-
RES <CON, P=0.02). The condition influenced the response over time for leptin concentration 
(condition x time interaction effect, P<0.001). Post-hoc analysis showed that leptin concentrations at 
D6 in CON, D-RES and E-RES were significantly lower by 30% (P=0.04, d=0.72), 59% (P<0.001, 
d>1.0) and 61% (P<0.001, d>1.0) from BASE prior to each experimental condition. Concentrations at 
D6 in D-RES (P<0.001, d=0.98) and E-RES (P<0.001, d=0.80) were also lower than those at D6 in 
CON (Table 2.).  
Mean 17β-oestradiol concentrations increased over time (main effect of time, P=0.002) which is in 
line with the progression of the menstrual cycle. All participants had 17β-oestradiol that indicated 
early or mid-follicular phase at the end of the protocol (D6, Minimum: 88.1 pmol·L
-1 
and Maximum: 
293.5 pmol·L
-1
), in accordance with data produced by Stricker et al [29]. 17β-oestradiol 
concentrations were not different between CON, D-RES and E-RES (main effect of condition, P=0.47) 
over time (condition x time interaction, P=0.30) (Table 2.). 
3.6. Individual analysis  
Individual responses for β-CTX and P1NP, as well as altered bone metabolism due to increased β-
CTX, decreased P1NP or both, in D-RES and E-RES trials are presented in Figure 1.  
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Table 2. Bone turnover markers, markers of calcium metabolism, metabolic and reproductive 
hormones in CON, D-RES and E-RES trials (n=10). Values at D2 were used as BASE prior to each 
experimental condition. (Size: 2 columns) 
Values are expressed as means±1SD. 
*
denotes a significant difference from BASE in the same condition (P<0.05). 
**
denotes a significant difference from CON at the same time point (P<0.05). 
 
β-CTX: C-terminal cross-linked telopeptides of type I collagen; P1NP: Amino-terminal pro-peptides of type 1 
procollagen; PTH: Parathyroid hormone; Mg: Magnesium; ACa:  Albumin adjusted Calcium; PO4: Phosphate; 
T3: Triiodothyronine; IGF-1: Insulin-like growth factor 1; GLP-2: Glucagon-like peptide 2; BASE: Baseline; 
CON: Controlled EA trial; D-RES: Low EA trial through diet; E-RES: Low EA trial through exercise.   
 CON   D-RES  E-RES  
 BASE D6 BASE D6 BASE D6 
Bone turnover markers 
β-CTX (µg·L-1) 0.50±0.19 0.51±0.18 0.48±0.18 0.55±0.17 0.47±0.24 0.49±0.18 
P1NP (µg·L
-1
) 56.7±16.9 52.5±11.9 54.8±12.7 45.2±9.3
*,**
 55.3±14.4 50.9±15.8 
Markers of calcium metabolism 
PTH (pg·mL
-1
) 4.4±1.1 3.8± 0.5 4.0±0.9 3.7±0.7 4.6±1.4 4.1±0.8 
ACa (mmol·L
-1
) 2.30±0.05 2.31 ±0.04 2.27±0.03 2.27±0.04 2.29±0.04 2.26±0.03 
Mg (mmol·L
-1
) 0.83±0.02 0.82±0.03 0.81±0.03 0.81±0.06 0.81±0.03 0.82±0.04 
PO4 (mmol·L
-1
) 1.29±0.12 1.28±0.12 1.26±0.14 1.31±0.08 1.33± 0.15 1.20±0.10
*
 
Metabolic and reproductive hormones 
IGF-1  
(mmol·L
-1)
 
205.0± 
39.4 
225.4± 
50.1 
202.5± 
46.8 
173.3± 
29.9
*, **
 
220.6± 
56.7 
169.2± 
49.6
*, **
 
T3 (mmol·L
-1
) 1.49±0.34 1.47±0.24 1.53±0.28 1.29± 
0.17
*,**
 
1.53±0.31 1.40±0.21 
Leptin (ng·mL
-1
) 7.6±3.7 5.1±3.1
*
 6.7±2.2 2.7±1.9
*, **
 8.0±4.9 3.0± 2.4
*, **
 
Insulin (pmol·L
-1
) 31.6±7.7 36.7± 20.9 33.8± 8.7 28.6±15.0 36.9±18.0 20.4±11.3 
17-β oestradiol 
(pmol.L
-1
) 
108.9± 33.6 157.3± 
53.1 
118.9± 
29.7 
157.9± 
 62.9 
148.3± 
92.9 
167.0± 
72.1 
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Figure 2. Number of responders (out of total number of participants) for β-CTX, P1NP and bone 
metabolism in D-RES and E-RES. Bone metabolism
1 
refers to altered bone metabolism due to 
increased β-CTX, decreased P1NP or both. Bone metabolism2 refers to altered bone metabolism due 
to a simultaneous increase in β-CTX and decrease in P1NP. This analysis was based on data 
expressed as % BASE for each participant. (Size: 2 columns).  
 
β-CTX: C-terminal cross-linked telopeptide of type I collagen; P1NP: Amino-terminal pro-peptides of type 1 
procollagen; BASE: Baseline; AUC: Area under the curve; CON:Controlled EA trial; D-RES: Low EA trial 
through diet; E-RES: Low EA trial through exercise.
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4. Discussion 
The effects of low EA on bone health in active individuals have received widespread attention in 
recent years due to the potential for stress fracture injury and long-term consequences for the 
development of osteoporosis [2, 6-8]. Most experimental studies have focused on low EA achieved by 
a combination of diet and exercise [9, 10, 30], whereas much less is known about the impact of low 
EA achieved by diet or exercise individually. By using a within participant design, our study findings 
show that 3-days of low EA achieved by dietary energy restriction resulted in a reduction in bone 
formation (P1NP, P<0.001, d=0.91), but had no effects on bone resorption. Low EA achieved by 
exercise energy expenditure did not significantly affect β-CTX or PINP, our measured markers of 
bone resorption and formation. Both low EAs were accompanied by similar reductions in metabolic 
hormones, suggesting that these may precede changes in bone turnover markers.  
The significant P1NP reduction (-17% from BASE), with no further change in β-CTX, shown in 
response to low EA achieved via dietary energy restriction, may reflect the degree of EA reached in 
this study and the short duration of low EA exposure (3 days). Ihle and Loucks [10] showed that bone 
resorption increased following a 5-day experimental period at the most severe level of low EA at 10 
kcal·kgLBM
-1
·d
-1
, but it remained unaffected at EA of 20 kcal·kgLBM
-1
·d
-1
. The importance of  the 
level of energy restriction for bone metabolism is also supported by a previous short-term fasting 
study (4 days), which resulted in synchronous reductions of bone formation (assessed by osteocalcin 
and P1CP-carboxyl-terminal propeptide of procollagen type I) and bone formation assessed by 
urinary pyridinoline and deoxypyridinoline [11] . Furthermore,  in non-obese adults, 12-month 
exposure to 25% restriction of dietary energy intake resulted in greater increases in CTX and tartrate-
resistant acid phosphatase (markers of bone resorption) and bone-specific alkaline phosphatase 
(marker of bone formation), but not P1NP [31]. Comparisons between studies are, however, difficult 
to make, due to differences in study population, duration and selection of bone turnover markers [10, 
11, 32]. We  measured P1NP for bone formation, and β-CTX for bone resorption, which are the 
reference standard markers in the published literature [33].  
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In our previous study [9], 5 days of low EA at 15 kcal·kgLBM
-1
·d
-1
, achieved by a combination of 
dietary energy restriction and exercise energy expenditure, resulted in significantly reduced bone 
formation (P1NP area under the curve (AUC); controlled EA: -23.1±34.9 %BASE x d , low EA: -
60.9±31.2 %BASE x d; P=0.01) and increased bone resorption (β-CTX AUC; controlled EA: 
16.9±68.1%BASE x d , low EA: 85.7±60.5 %BASE x d, P=0.03) compared to the controlled 
condition (45 kcal·kgLBM
-1
·d
-1
) in active eumenorrheic women. These results also support the notion 
that the duration of exposure is an important consideration for the negative effect of low EA on bone 
turnover markers, and imply that an experimental period longer than 3 days is required to elicit greater 
changes in bone metabolism in response to this level of low EA.  
Exercise-induced low EA at 15 kcal·kgLBM
-1
·d
-1
 did not significantly alter bone formation (-8% from 
BASE in P1NP) or bone resorption (+12% from BASE in β-CTX). Our exercise intervention involved 
2-2.5 h of running at a moderate intensity (70% VO2 peak) for 3 consecutive days, which is a common 
training routine followed by some active populations [34, 35]. Our participants were physically active 
and habitually performed moderate and vigorous exercise, they were, however, unaccustomed to such 
a prolonged duration of daily running over consecutive days. Some osteogenic effects due to the non-
habitual duration and frequency of mechanical loading on weight bearing sites may have occurred [36] 
and counterbalanced local bone loss due to low EA in other skeletal sites (e.g., non-weight bearing 
sites).  In our study the indirect assessment of bone metabolism (by measuring bone turnover markers 
in blood samples), provides insight into systemic, rather than localised, effects of low EA.  
There were no significant differences between the diet-induced and exercise-induced low EAs. It is 
uncertain, if the responses in bone turnover markers shown for diet-induced and exercise-induced low 
EA would persist over time or whether we were unable to capture any differences due to the short 
duration of our experimental protocol. Analysis of changes in bone turnover markers for each 
individual showed that 8 out of 10 and 5 out of 10 participants experienced increased β-CTX, 
decreased P1NP or both in the diet- and exercise induced low EA trial; suggesting that a subset of 
women may adversely respond to low EA, especially following low EA achieved by dietary energy 
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restriction. Further research should expand upon the present study by comparing the effects of low EA 
achieved by dietary restriction, exercise energy expenditure, and a combination of both. 
Whilst we have no comparable data from short-term studies in active individuals, observational 
studies suggest that mechanical loading exerts beneficial effects on the skeleton, which may 
counteract some of the unfavourable effects of low EA [37-40]. For instance, dancers with 
amenorrhea (presumably energy deficient) have greater BMD at weight bearing sites (e.g., proximal 
femur, lumbar spine) compared to girls with anorexia nervosa with similarly low body mass, but both 
groups experience comparable bone loss at non-weight bearing skeletal sites [40]. Athletes 
participating in weight sensitive, non-weight bearing sports (e.g., cyclists, jockeys) are at a greater 
risk for developing low bone mass than those partaking in weight bearing activities (e.g., boxers; 
gymnasts) [37, 38, 39].  Collectively, these findings suggest that mechanical loading through exercise 
may have some bone-sparing effects under long-term energy deficiency and support the findings of 
this short-term study showing no change in P1NP concentrations following low EA achieved via 
exercise energy expenditure, but a reduction in this bone formation marker when the same of low EA 
was achieved through dietary energy restriction.  
The osteoprotective effects of exercise in weight loss programmes have been also demonstrated in 
interventional studies in middle-aged or eldelrly overweight/obese individuals [16-19, 41]. For 
example, Villareal et al. reported that the addition of exercise on a weight loss programme 
ameliorated diet-induced weight loss reductions in hip BMD in obese older adults [19]. Parallel 
positive effects were seen on fat mass, and muscle mass, strength and function [19, 42]. Altough there 
are a number of differences between lean, active individuals and overweight/obese, mostly sedentary 
individuals, and the characteristics of exercise interventions targeting these groups vary greatly, these 
changes are suggestive of cross-talk between muscle, adipose tissue and bone under conditions of low 
EA. Inclusion of  body composition and muscle function measurments, but also, assessment of factors 
released by muscles and adipose tissue with potential osteogenic effects [43, 44] in future research in 
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this area will provide further evidence on the adipose tissue, muscle and bone interactions in response 
to exercise-induced low EA in active individuals.  
Reductions in IGF-1, leptin, T3 and insulin, indicative of energy conservation, were shown following 
the low EA conditions in the present study, which is in agreement with those of short-term energy 
deficiency experiments [9-11, 24]. Specifically, decreases in IGF-1 and leptin were shown 
independently of whether low EA was achieved by diet or exercise. Decreases in T3, however, 
occurred in the diet-induced low EA condition only and insulin decreased following exercise-induced 
low EA only. When comparing diet- and exercise-induced low EAs, there were no differences in 
regulatory hormone concentrations, which is in line with previous findings in a study in active men 
using the same level of low EA (15 kcal·kg LBM
-1
·d
-1
) achieved through diet only or combined with 
exercise [24]. 
Neither low EA condition caused a significant change in 17β-oestradiol concentrations. These results 
are in line with our 17β-oestradiol findings following 5 days at the same level of low EA achieved by 
dietary energy restriction combined with exercise in active women [9]. In contrast, a 15% reduction in 
24-h mean oestrogen concentrations that occurred in parallel with an increase in bone resorption 
[urinary N-terminal telopeptide] was reported following 5 days of low EA, attained through diet and 
exercise at 10 kcal·kgLBM
-1
·d
-1
, but not 20 kcal·kgLBM
-1
·d
-1
 [10]. The discrepancies between the 
studies may in part be due to our less severely reduced EA (15 vs. 10 kcal·kgLBM
-1
·d
-1
) or blood 
sampling schedule (single sample vs. 24-h frequent blood collection) [10]. LH pulsatility and 
testosterone concentrations, not determined in the current study, may also be negatively affected in 
response to low E  [45, 46]. LH pulsatility was suppressed following 5 days of EAs at 10 and 20 
kcal·kgLBM
-1
·d
-1
, with these findings suggesting that changes in gonadotrophins secreted by the 
anterior pituitary may occur prior to changes in ovarian production of oestrogen in states of energy 
deficiency [45]. In this study, we purposefully chose the  follicular phase phase of the menstrual cycle 
because oestrogen levels are less variable compared to other phases of the menstrual cycle. 
Furthermore, the initiation of this phase of the menstrual cycle can be easily identified (i.e., first day 
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of bleeding). Future studies should explore different phases of the menstrual phase (e.g., ovulation, 
luteal) or include women with different menstrual status (i.e., amenorrheic or oral contraceptive users), 
while measuring more reproductive hormones (i.e., LH pulsatility and testosterone) in relation to 
bone-related outcomes.  
Restriction of bone-related macronutrients (i.e., protein) or micronutrients (i.e., calcium) during 
periods of energy restriction may contribute to changes in bone metabolism [47]. Herein the 
variability in macronutrient distribution within and between participants was eliminated by feeding 
our participants with the same food items and dietary composition. We also provided a multi-mineral, 
multi-vitamin supplement in the diet-induced low EA trial only to limit the influence of changes in 
micronutrient provision. There was, however, a small reduction in PO4, when low EA was achieved 
by exercise energy expenditure. Changes in systemic PO4 can have an impact on PTH secretion, with 
[48] showing that alterations in PO4 precede changes in PTH. That said, PTH did not change in the 
exercise-induced low EA condition, maybe due to the small PO4 changes or because of the short 
timeframe of the study.  
5. Conclusions 
The decrease in bone formation with low EA achieved by diet, but not by exercise alone, suggests that 
efforts to protect bone health should possibly focus on improving diet and not by modulating exercise 
levels. Future studies with a longer duration of reduced energy availability and a larger sample size 
should confirm these findings and identify the mechanisms that mediate low EA effects on bone 
turnover markers, since leptin and IGF-1 responded similarly to both conditions in this study.  
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Highlights  
 
 We explored the effects of low energy availability (EA) achieved by diet or exercise 
on bone metabolism in active women. 
 Low EA achieved by dietary energy restriction (3-days) resulted in decreased bone 
formation, but did not influence bone resorption.  
 Low EA achieved by exercise energy expenditure did not affect bone metabolism.  
 No differences in bone metabolic responses were shown between diet- and exercise-
induced low EAs within the timeframe of this study.  
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